Pancreatic Cancer Research

ResearcherUniversity of KochiNo recent work listed

Tetsuji Naka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1269-3997; OpenAlex author ID A5020771892, A5086037123. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
23
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper

Papers 6

  1. Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.2967/jnumed.123.266313↗
  2. A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell car… Last author DOI 10.1016/j.neo.2021.07.006↗
  3. Glypican-1 Is a Novel Target for Stroma and Tumor Cell Dual-Targeting Antibody-Drug Conjugates in Pancreatic Cancer. Last author DOI 10.1158/1535-7163.mct-21-0335↗
  4. Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer. Last author DOI 10.1038/s41416-020-0781-2↗
  5. Epithelial-mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine-rich alpha-2… Last author DOI 10.1111/cas.13918↗
  6. Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000205↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shigehiro Tsujii · 3 shared papers, 2020–2021 · strength 0.33
  2. Sunao Uemura · 2 shared papers, 2021 · strength 0.25
  3. Kazuhiro Hanazaki Md · 2 shared papers, 2021 · strength 0.25
  4. Yuichiro Doki · 3 shared papers, 2015–2020 · strength 0.20
  5. Hidetoshi Eguchi · 3 shared papers, 2015–2020 · strength 0.20
  6. Toru Otsuru · 2 shared papers, 2019–2020 · strength 0.16
  7. Tadashi Watabe · 1 shared paper, 2023 · strength 0.15
  8. Noriyuki Tomiyama · 1 shared paper, 2023 · strength 0.15
  9. Eri Munekage · 1 shared paper, 2021 · strength 0.11
  10. Takahiko Nishigaki · 1 shared paper, 2020 · strength 0.08
  11. Masaki Mori · 1 shared paper, 2020 · strength 0.08
  12. Tadafumi Asaoka · 1 shared paper, 2019 · strength 0.08
  13. Yoshifumi Iwagami · 1 shared paper, 2019 · strength 0.08
  14. Daisaku Yamada · 1 shared paper, 2019 · strength 0.08
  15. Kunihito Gotoh · 1 shared paper, 2019 · strength 0.08
  16. Masahiro Tanemura · 1 shared paper, 2015 · strength 0.04
  17. Hirofumi Akita · 1 shared paper, 2015 · strength 0.04
  18. Tsukasa Tanida · 1 shared paper, 2015 · strength 0.04
  19. Yoshito Tomimaru · 1 shared paper, 2015 · strength 0.04
  20. Shinichiro Shinzaki · 1 shared paper, 2015 · strength 0.04
  21. Hiroaki Nagano · 1 shared paper, 2015 · strength 0.04
  22. Eiji Miyoshi · 1 shared paper, 2015 · strength 0.04
  23. Kenta Furukawa · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.